These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25684421)

  • 1. Synthesis and biological evaluation of 4-nitroindole derivatives as 5-HT2A receptor antagonists.
    Hayat F; Viswanath AN; Pae AN; Rhim H; Park WK; Choo HY
    Bioorg Med Chem; 2015 Mar; 23(6):1313-20. PubMed ID: 25684421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity.
    Ponnala S; Gonzales J; Kapadia N; Navarro HA; Harding WW
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1664-7. PubMed ID: 24630561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M; Lim HD; Herenbrink CK; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2015 Feb; 58(3):1550-5. PubMed ID: 25590655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of PDZ ligands as inhibitors of 5-HT(2A) receptor/PSD-95 PDZ1 domain interaction possessing anti-hyperalgesic activity.
    Vogrig A; Dorr L; Bouzidi N; Boucherle B; Wattiez AS; Cassier E; Vallon G; Ripoche I; Abrunhosa-Thomas I; Marin P; Nauton L; Thery V; Courteix C; Lian LY; Ducki S
    ACS Chem Biol; 2013 Oct; 8(10):2209-16. PubMed ID: 23895101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.
    Gianotti M; Botta M; Brough S; Carletti R; Castiglioni E; Corti C; Dal-Cin M; Delle Fratte S; Korajac D; Lovric M; Merlo G; Mesic M; Pavone F; Piccoli L; Rast S; Roscic M; Sava A; Smehil M; Stasi L; Togninelli A; Wigglesworth MJ
    J Med Chem; 2010 Nov; 53(21):7778-95. PubMed ID: 20942472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.
    Chaudhary S; Ponnala S; Legendre O; Gonzales JA; Navarro HA; Harding WW
    Bioorg Med Chem; 2011 Oct; 19(19):5861-8. PubMed ID: 21900013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.
    Kapadia N; Harding WW
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3451-4. PubMed ID: 26227772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
    Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
    J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT
    Poulie CBM; Liu N; Jensen AA; Bunch L
    J Med Chem; 2020 Sep; 63(17):9928-9949. PubMed ID: 32815361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.
    Cummings DF; Canseco DC; Sheth P; Johnson JE; Schetz JA
    Bioorg Med Chem; 2010 Jul; 18(13):4783-92. PubMed ID: 20570529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
    Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
    Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands.
    Chang-Fong J; Tyacke RJ; Lau A; Westaway J; Hudson AL; Glennon RA
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1003-5. PubMed ID: 15013010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
    Gilbertson SR; Chen YC; Soto CA; Yang Y; Rice KC; Cunningham KA; Anastasio NC
    Bioorg Med Chem Lett; 2018 May; 28(8):1381-1385. PubMed ID: 29555153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.
    Eliás O; Agai-Csongor E; Domány G; Keserű GM; Gere A; Kiss B; Hellinger E; Vastag M; Gyertyán I
    Bioorg Med Chem Lett; 2014 May; 24(9):2118-22. PubMed ID: 24717153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A; Yamada H; Matsuzawa-Nomura T; Watanabe T; Itahana H; Oku M; Akuzawa S; Okada M
    Bioorg Med Chem; 2014 Nov; 22(21):6026-38. PubMed ID: 25281269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.